Raised B-type natriuretic peptide predicts implantable cardioverter-defibrillator therapy in patients with ischaemic cardiomyopathy. Issue 9 (14th August 2006) - Klingenberg, R; Zugck, C; Becker, R; Schellberg, D; Heinze, G; Kell, R; Remppis, A; Schoels, W; Katus, H A; Dengler, T J